| 产品详情 |
| Edit |   |
|---|
| Product Name | CBL-BSA |
|---|
| Description | • Provided at 0.1 mg/mLCarbamylation is a post-translational modification which occurs throughout the lifespan of proteins in vivo. Carbamylation results from the binding of isocyanic acid, spontaneously derived from high concentrations of urea and leading to the formation of carbamyl-lysine (CBL) (Figure 1). The carbamylation of proteins is usually associated with a partial or complete loss of protein function. It is known that elevated urea directly induces the formation of p |
|---|
| Size | 0.01 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [CBL-BSA] |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | MBS168409 |
|---|
| Price | |
|---|
| Order / More Info | CBL-BSA from MYBIOSOURCE INC. |
|---|
| Product Specific References | 1. Wang, Z., et al. (2007). Nat. Med. 13:1176-1184. 2. Kraus, L.M., et al. (2001). Swiss Med. Wkly. 131:139-144. 3. Sirpal, S. (2009). Clin. Sci. (Lond.) 116:681-695. 4. Balion, C.M., et al. (1998). Kidney Int. 53:488-495. 5. Asci, G., et al. (2008). Nephrology (Carlton) 13:480-486. 6. Jaisson, S., et al. (2007). FEBS Lett. 581:1509-1513. 7. Garnotel, R., et al. (2004). FEBS Lett. 563:13-16. |
|---|
| 产品资料 |
|
|